Polypharmacy reasoned about on the prescribing screen, a G6PD flag before an unsafe drug, and older patients’ lists reviewed on schedule.
Installs with RxCanvas, whose screen it works onInstalling it installs RxCanvas. On the prescribing screen it is the AI layer above the deterministic drug-interaction table: the whole medication list is reasoned about — duplications, cascades and dose problems a pair-by-pair table cannot see — grounded on the interaction rows the hospital’s own licensed dataset produced and on nothing else, with the gateway refusing the call outright if that grounding is absent; what comes back is prose a prescriber reads beside those rows, and the deterministic list is still shown when AI is off. A patient the record shows as G6PD-deficient — a status recorded with its source, the problem list or an allergy entry — is flagged the moment a drug on the practice’s own unsafe list is reached for, beside the interaction warnings, and proceeding needs a typed reason; every flag is logged. Its Medication review screen reviews an older patient’s whole list on the practice’s schedule (the age and interval are the practice’s, with their source) against the practice’s reading of the AGS Beers Criteria, each flagged medicine put to the prescriber to continue, taper, substitute or stop, the decision recorded with its reason.
/medication-reviewprescription.readWhat it does not do, by design. A listing with only benefits is an advertisement.
Tell us what you run and we will show you this app inside a practice shaped like yours — or answer the question the page above did not.